Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.
about
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.Virus-mediated autoimmunity in Multiple Sclerosis.Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisRedox regulation of T-cell function: from molecular mechanisms to significance in human health and diseaseMultiple sclerosisPharmacological Approaches to Delaying Disability Progression in Patients with Multiple SclerosisNeuroprotection in a novel mouse model of multiple sclerosisMyelin-associated glycoprotein (MAG): past, present and beyondPathology of multiple sclerosis: where do we stand?Disruption of axo-glial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axonsComplementary and alternative medicine for the treatment of multiple sclerosisVariants of ST8SIA1 are associated with risk of developing multiple sclerosis.Quantitative electroencephalography reveals different physiological profiles between benign and remitting-relapsing multiple sclerosis patientsSexual Therapy for Women with Multiple Sclerosis and Its Impact on Quality of Life.Purkinje Cell Degeneration and Motor Coordination Deficits in a New Mouse Model of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.Multiple sclerosis: Pathology, diagnosis and treatments.In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique.Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelinationClinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital.Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.Gene therapy with mitochondrial heat shock protein 70 suppresses visual loss and optic atrophy in experimental autoimmune encephalomyelitis.The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in miceThe immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis miceReview: Mitochondria and disease progression in multiple sclerosisThe role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapiesPerturbed glucose metabolism: insights into multiple sclerosis pathogenesisPotential triggers of MSXanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosisNeurotrophin-3 targets the translational initiation machinery in oligodendrocytes.A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitisComplex I subunit gene therapy with NDUFA6 ameliorates neurodegeneration in EAEGene therapy in autoimmune, demyelinating disease of the central nervous system.Role of pathogens in multiple sclerosisT-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis.Altered cerebellar functional connectivity mediates potential adaptive plasticity in patients with multiple sclerosis.Multiple sclerosis and vitamin D: an update.Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice.Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegenerationIFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
P2860
Q21146752-214B56AD-4BA9-4430-BAB4-93A1FD5A8826Q25256901-419D88D4-D0A2-4657-8E58-B56ACB8CC3D7Q26744629-91BE4AD4-28A1-4BAD-BC47-423331C07B33Q26824042-88BBFA28-9839-4084-8923-65C268ED5B38Q26995437-5375BF41-8E7E-433C-BD84-9988465BCB7EQ27000269-BFC4F1AA-CE05-401B-9ED0-6DFCF83E0554Q27302918-06D32BDD-BBC9-49BB-865E-1DBC2E65C205Q28284415-947D4277-5E07-402D-87DD-E2F52A35C7DDQ28296052-E083BFFB-7E08-468A-BF2E-CF24BFA1EED5Q28591753-AB36F5C1-B4FE-4272-8187-037F1BCDD0EFQ29031018-F1CB5AB8-874F-4334-B2C3-F3300B31C517Q33350182-D76B8FF1-E98E-4593-983B-B6410DC68CC8Q33386254-8F0EEF92-F79B-4E0A-A1E3-6AB8D781F2E4Q33658420-EE263021-B0E0-4F75-B789-49A45D96E7D1Q33713866-A2DA9C4D-F2D1-4ECA-9610-D6FD3F1180DBQ33745006-FCFB02B8-6C79-487E-84A7-D0667DB004D3Q33823782-C36C68B0-7F12-4D1E-8736-9CFC2A446ADFQ34027469-467F73C2-1782-4FC4-9C8F-8D03985A42C8Q34045441-5962183F-DBB2-4FF2-AA2A-FDB7D9DF5C81Q34055604-609D058C-A44F-467D-833F-E020EEDADB71Q34069978-22D4D4B4-71E5-4217-9E01-15DD8C2D4524Q34087938-489F28B3-3558-4B31-9664-4D4AAEDA1B1CQ34245104-AC3E21CE-E954-454F-8A82-9D3EE97C28A0Q34308687-FB0695A8-CE2F-467A-B8F3-A9BD1E581327Q34468304-622ECBA8-4BB5-4DD1-88E4-93D82BD34178Q34512363-0930A38A-C812-41C4-A804-0EAFCF1E4083Q34595607-1BF20172-5DC5-48B7-A8D0-E8CED4DBF1E9Q34624709-F9B9DFC1-7F6D-4AB4-8AB4-594A76487EFDQ34949303-62919778-2A5D-40CB-9FA5-498A1C467874Q34992053-643D0A7C-CD9E-4EB1-880C-F6C89B8A1939Q35085079-9ACC1B2B-0766-4832-B89A-FD4D9156321AQ35087742-F37B78CE-4089-4556-9F1C-3D75042A99CFQ35122159-B986C0CB-A14F-4856-917C-9899BAB1FBCCQ35206805-92E3DFB8-9424-45D5-ADA2-9406F9FD203DQ35222043-0118FD9E-6027-42D9-AB79-1134D03EE3C3Q35480805-B9491407-5B38-45A7-A8C8-2F8F575629CFQ35726340-70E4530B-2D9A-4179-8B98-46086429F5F8Q35751923-BA0FC557-A50F-4187-BCD6-1F14691E0335Q35757231-CF36F8DF-E935-4A01-A9D6-9CE60AAD37B8Q35800253-A2BC0FD6-3501-4AC2-BB15-E5B1E9665BFF
P2860
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Axonal loss in the pathology o ...... gressive phase of the disease.
@ast
Axonal loss in the pathology o ...... gressive phase of the disease.
@en
type
label
Axonal loss in the pathology o ...... gressive phase of the disease.
@ast
Axonal loss in the pathology o ...... gressive phase of the disease.
@en
prefLabel
Axonal loss in the pathology o ...... gressive phase of the disease.
@ast
Axonal loss in the pathology o ...... gressive phase of the disease.
@en
P2093
P1476
Axonal loss in the pathology o ...... gressive phase of the disease.
@en
P2093
P304
P356
10.1016/S0022-510X(02)00069-2
P577
2003-02-01T00:00:00Z